Skip to content
DraconiticResearch
Search Sources API
197,693 studies31 sourcesUpdated 26 min ago
Peer-reviewedCC BY-NC-NDIScience

HDAC inhibitor treatment restores transcriptome, chromatin accessibility, and memory deficits in a mouse model for Down syndrome

Related

  1. A druggable chromatin vulnerability in suppressive neutrophils restores antitumor immunity
    F. Yang, Y. Bao, Y. Qiao +29
    bioRxivPreprintCC BYFull textOncologybioRxiv
  2. FHL1 Downregulation Is Specific to Cancer-Associated Fibroblasts and Linked to Reduced Chromatin Accessibility in Colorectal Cancer.
    Abdullah A Alqasem, Waad Al-Burayk, Muneira Habjar +9
    GenesPeer-reviewedCC BYFull textOncologyEurope PMC
  3. SUMO2 deletion changes chromatin accessibility and enhances cytotoxic T cell activation and tumor infiltration
    Mohottige D. Neranjan Tharuka, Dai-Hua Chen, Maria Luisa Jurgensen Amaral +8
    Science AdvancesPeer-reviewedCC BY-NCOncologyCrossref
  4. Genetic regulation of cell type–specific chromatin accessibility contributes to migraine etiology
    Qiuhan Xu, Zhaohui Chai, Yuning Zhang +1
    The Journal of Headache and PainPeer-reviewedCC BYFull textPsychiatry & mental healthDOAJ
  5. MAPK signaling links BRD2 chromatin occupancy to PI3K/AKT inhibitor sensitivity
    J. Mendez, S. Bruno, A. Indeglia +12
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
BibTeX
@article{sierra2026hdac,
  title = {{HDAC inhibitor treatment restores transcriptome, chromatin accessibility, and memory deficits in a mouse model for Down syndrome}},
  author = {Cesar Sierra and René A.J. Crans and Mara Dierssen},
  journal = {IScience},
  year = {2026},
  month = sep,
  doi = {10.1016/j.isci.2026.117670},
  url = {https://europepmc.org/article/PMC/PMC13657111},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - HDAC inhibitor treatment restores transcriptome, chromatin accessibility, and memory deficits in a mouse model for Down syndrome
AU  - Cesar Sierra
AU  - René A.J. Crans
AU  - Mara Dierssen
PY  - 2026
DA  - 2026/09/30
JO  - IScience
DO  - 10.1016/j.isci.2026.117670
UR  - https://europepmc.org/article/PMC/PMC13657111
SN  - 2589-0042
ER  -